Skip to content

Heading to World Orphan Drug Congress in Boston? Learn how we can help accelerate access to patients in Europe. Talk to our team

Leverage patient-reported data and PROMs to improve outcomes in oncology

Katie Duncalf

By Katie Duncalf

Digital Commercialisation & Partnership Lead - Global

Bridge the gap between traditional and holistic care

For pharmaceutical companies, the integration and utilisation of Patient Reported Outcomes (PROs) data in oncology care presents unique opportunities. This data can demonstrate patient-centred care, enhance brand value, differentiate in a competitive market, and foster patient trust. PROs are bridging the gap between traditional clinical endpoints and providing a more holistic approach to care. This leads to improved overall patient outcomes.

This paper explores:

  • The role of PROs in oncology care
  • Impact on patient outcomes and brand perception
  • Challenges in integrating and utilising patient-reported data
  • Strategies for effective integration of PROs and Patient Reported Outcome Measures (PROMs)
  • Pharma’s role in optimising patient-reported data

Download this free paper to understand the essential role of PROs and PROMs in cancer care and subsequent benefits to Pharma.

Meet our expert

Katie Duncalf

Digital Commercialisation & Partnership Lead – Global

Katie leads the digital commercialisation arm of our Digital+ market. She is an expert in designing and implementing patient-centric digital solutions across therapeutic areas.

Sciensus

About Sciensus

Sciensus is a proven life sciences solutions partner with more than 30 years’ experience in navigating and unlocking the complex European healthcare ecosystem to maximise patient reach. We help accelerate the development journey, bringing medicines into the market and directly to patients to improve health outcomes. Through cutting-edge patient engagement programmes, offering an exclusive combination of skilled in-person care and digital support, we help patients make the most of their treatment and generate real-world evidence that can be used to improve treatment pathways.

Learn more